The Clinical Research Support Office (CRSO) brings you the new guidelines for Investigational New Drug (IND) and Investigational Device Exemption (IDE) as of Fall 2024. The purpose of the guidelines is to outline processes for IND and IDE application preparation, submission, and management at the University of Utah.

Click here to read the entire FDA IND and IDE Working Guidelines.

For further questions, please reach out to Jonna Davis.